S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:IBB

iShares Biotechnology ETF (IBB) Stock Forecast, Price & News

$115.61
+0.58 (+0.50%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$112.60
$116.39
50-Day Range
$106.46
$134.76
52-Week Range
$105.39
$177.37
Volume
1.85 million shs
Average Volume
3.55 million shs
Market Capitalization
$7.55 billion
P/E Ratio
N/A
Dividend Yield
0.27%
Beta
0.92
30 days | 90 days | 365 days | Advanced Chart
Receive IBB News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer BlackRock
Fund NameiShares Nasdaq Biotechnology ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:IBB
Inception Date2/5/2001
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNASDAQ Biotechnology Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$7.70 billion
Average Daily Volume$2.62 million
Discount/Premium0.08%

ETF Expenses

Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of IBB

Currency Exposure of IBB

Sector Exposure of IBB

Industry Exposure of IBB














iShares Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions

How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF?

iShares Biotechnology ETF announced a quarterly dividend on Wednesday, March 23rd. Stockholders of record on Friday, March 25th will be paid a dividend of $0.118 per share on Wednesday, March 30th. This represents a $0.47 dividend on an annualized basis and a dividend yield of 0.41%. The ex-dividend date is Thursday, March 24th. This is a boost from iShares Biotechnology ETF's previous quarterly dividend of $0.04.
View iShares Biotechnology ETF's dividend history
.

Is iShares Biotechnology ETF a good dividend stock?

iShares Biotechnology ETF pays an annual dividend of $0.31 per share and currently has a dividend yield of 0.27%.
View iShares Biotechnology ETF's dividend history.

When did iShares Biotechnology ETF's stock split? How did iShares Biotechnology ETF's stock split work?

iShares Biotechnology ETF shares split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Biotechnology ETF stock prior to the split would have 300 shares after the split.

Who are iShares Biotechnology ETF's key executives?
iShares Biotechnology ETF's management team includes the following people:
  • George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
  • Michael Arthur Latham, President, Trustee
  • Jack Gee, Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
  • , Bio & Compensation - 
  • Amy Schioldager, Executive Vice President
  • Ira P. Shapiro, Vice President, Chief Legal Officer
  • Matt Tucker, Vice President
  • , Bio & Compensation - 
  • Eilleen M. Clavere, Secretary
  • Cecilia H. Herbert, Independent Trustee
  • Charles A. Hurty, Independent Trustee
What other stocks do shareholders of iShares Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

What is iShares Biotechnology ETF's stock symbol?

iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

Who are iShares Biotechnology ETF's major shareholders?

iShares Biotechnology ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include UBS Group AG (3.10%), Citigroup Inc. (3.03%), Goldman Sachs Group Inc. (2.42%), Royal Bank of Canada (1.97%), JPMorgan Chase & Co. (0.98%) and Commerce Bank (0.91%).

Which major investors are selling iShares Biotechnology ETF stock?

IBB stock was sold by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, Bank Julius Baer & Co. Ltd Zurich, Jane Street Group LLC, Alpha Cubed Investments LLC, Mmbg Investment Advisors CO., Cutler Group LP, Royal Bank of Canada, and Cetera Advisor Networks LLC.

Which major investors are buying iShares Biotechnology ETF stock?

IBB stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Citigroup Inc., Hackensack Meridian Health Inc., UBS Group AG, JPMorgan Chase & Co., Tredje AP fonden, Atria Wealth Solutions Inc., and First Interstate Bank.

How do I buy shares of iShares Biotechnology ETF?

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $115.61.

How much money does iShares Biotechnology ETF make?

iShares Biotechnology ETF has a market capitalization of $7.55 billion.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.